Significant advances in systemic treatment options have positively impacted breast cancer survivorship.

This activity begins with discussion on optimal ways to identify high risk patients, approaches to patient education for all women, with a specific focus on those women disproportionately affected by BCRL/UED, and clinical workflows for high risk patients/those who have already developed BCRL/UED

Patient fertility and sexual complications have few data available from clinical trials. It is noteworthy that the subject is infrequently discussed in institutional peer reviews/ M&M unless there is a Risk Management overlay.

Breast cancer recurrence after prior definitive multimodality treatment is an increasingly common clinical situation faced by practitioners, with long-term new primary or recurrent non-metastatic locoregional recurrence developing not infrequently over 10 years following initial treatment.

This is a case-based panel activity, with a surgeon, a medical oncologist and a radiation oncologist. Each speaker reviews the current and ongoing studies addressing treatment de-intensification in their area of expertise.

There are multiple new developments in the treatment of breast cancer patients with radiation therapy, as well as ongoing developments in the use of breast IMRT. Practicing clinicians need to stay informed to improve outcomes among breast cancer patients.